Top Story

Increased imaging improved early detection in well-differentiated thyroid cancer

October 31, 2014

CORONADO, Calif. — Patients diagnosed with well-differentiated thyroid cancer after 2000 were more likely to exhibit lower risk disease, according to study results presented at the American Thyroid Association Annual Meeting.

Researchers noted that the use of post-diagnosis imaging has increased among all patients, regardless of the level of disease, with the largest growth observed in the use of PET scans.

In the Journals

Weekly prophylaxis with nonacog beta pegol safe, effective for hemophilia B

October 31, 2014
Nonacog beta pegol effectively treated bleeding episodes and was associated with low annualized bleeding rates in patients with hemophilia B, according to study…
figure Video

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at the University of Pennsylvania, discusses study…
Worth Building

Question your allocation to deal with recent stock market volatility

October 30, 2014
The summer stock market doldrums have morphed into a high octane volatile zig-zag. So I ask you – what is new? Haven’t we been here before? The trouble is…
More News Headlines »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Video
figure

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at…
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »